Article info
What neurologists need to know outside their speciality
Diffuse multiple sclerosis and chronic central serous chorioretinopathy: pitfall not to ignore
- Correspondence to Andrei Drimbea, Department of Ophthalmology, Jules Verne University, Clinic Saint Victor 354 Boulevard de Beauville, Amiens Cedex 1 80054, France; drimbea_andrei{at}yahoo.com
Citation
Diffuse multiple sclerosis and chronic central serous chorioretinopathy: pitfall not to ignore
Publication history
- Received June 22, 2012
- First published March 13, 2013.
Online issue publication
April 14, 2016
Article Versions
- Previous version (14 April 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions
Other content recommended for you
- Photodynamic therapy for steroid-associated central serous chorioretinopathy
- Retinal and choroidal changes observed with ‘En face’ enhanced-depth imaging OCT in central serous chorioretinopathy
- Two-year follow-up of mineralocorticoid receptor antagonists for chronic central serous chorioretinopathy
- Optical coherence tomography angiography of flat irregular pigment epithelial detachments in central serous chorioretinopathy
- Safety enhanced photodynamic therapy with half dose verteporfin for chronic central serous chorioretinopathy: a short term pilot study
- Spironolactone versus observation in the treatment of acute central serous chorioretinopathy
- Discrepancy in current central serous chorioretinopathy classification
- Long-term efficacy of half-dose photodynamic therapy on chronic central serous chorioretinopathy
- Mimics and chameleons of optic neuritis
- Choroidal vascular remodelling in central serous chorioretinopathy after indocyanine green guided photodynamic therapy with verteporfin: a novel treatment at the primary disease level